T-DM1 Articles
Roche affiliate Chugai files for T-DM1 approval in Japan; gains rights to Afraxis compound
30 January 2013
More highlights from ESMO Congress
2 October 2012
Genentech's T-DM1 significantly improved survival for metastatic breast cancer patients
29 August 2012
Showing 1-3 of 3 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
